
Progestin Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 50 mg/mL, 100 mg/mL
Reference Brands: Depo-subQ Provera 104(US)
Category: Oncology Cancer Care
Progestin Injection is available in Injection and strengths such as 50 mg/mL, 100 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Progestin Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Progestin Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Progestin Injection (50 mg/mL and 100 mg/mL), often in the form of Medroxyprogesterone acetate, is used in oncology to manage hormone receptor-positive breast cancer, recurrent endometrial cancer, and palliative care for various cancer symptoms. Approved in both the U.S. and EU, it plays a critical role in hormonal therapy, working to slow cancer progression by blocking hormone receptors. Available as an IM or subcutaneous injection, it is a key drug in oncology B2B distribution, supporting hospitals and cancer treatment centers with its ability to control tumor growth and improve patient quality of life.
Frequently Asked Questions
Related Products
Atezolizumab
Strength: 1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View DetailsDurvalumab
Strength: 120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View DetailsSunitinib
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers